Marc Lustig

Marc Lustig

Chief Executive Officer presso PHARMACIELO LTD.

Patrimonio netto: 7 M $ in data 31/03/2024

51 anni
Finance
Process Industries
Health Technology

Profilo

Marc Lustig is the founder of Cannabis Royalties & Holdings Corp.
(founded in 2016), CannaRoyalty Corp.
(founded in 2015), and Trichome Financial Corp.
(founded in 2017).
He held the titles of Chief Executive Officer & Director at Cannabis Royalties & Holdings Corp., Executive Chairman & Chief Executive Officer at CannaRoyalty Corp., and Chairman at Trichome Financial Corp.
Mr. Lustig was also the founder of Cedars Cancer Foundation.
His current jobs include Chairman & Chief Executive Officer at PharmaCielo Ltd.
(since 2020), Executive Chairman at IM Cannabis Corp.
(since 2019), Director at Cresco Labs LLC, Director at Aequus Pharmaceuticals, Inc. (since 2021), Independent Director at BriaCell Therapeutics Corp.
(since 2021), Director at Resolve Digital Health, Inc., Director at Cresco Labs, Inc. (since 2020), Director at Trichome Financial Corp.
(since 2019), Director at L5 Capital, Inc., and Director at Cresco Labs, Inc. (Arizona) (since 2021).
His former jobs included Chairman at Meta Growth Corp.
(2017-2020), Chairman at Trichome Financial Corp., Chairman at Wellfield Technologies, Inc. (2021-2023), Director at RF Capital Group, Inc., Independent Director at 22 Capital Corp., Independent Director at Planet 13 Holdings, Inc. (2018-2019), Head-Capital Markets at Merck & Co., Inc., Principal at Griffiths McBurney Corp., Head-Capital Markets at Dundee Capital Markets, Inc. (2012-2014), Sales Associate at GMP Securities LP, Vice President at Orion Securities, Inc., and Principal at KES 7 Capital, Inc.Mr. Lustig's education included a graduate degree and an MBA from McGill University.
Mr. Lustig is also the founder of Cedars Cancer Foundation.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
20/12/2023 1 660 000 ( 10.39% ) 5 M $ 31/03/2024
11/04/2024 5 341 238 ( 3.35% ) 908 010 $ 31/03/2024
28/03/2024 930 635 ( 6.95% ) 493 237 $ 31/03/2024
13/09/2023 7 261 339 ( 4.57% ) 370 328 $ 31/03/2024
26/06/2023 6 879 725 ( 13.60% ) 213 271 $ 31/03/2024
20/09/2023 6 400 000 ( 11.40% ) 153 600 $ 31/03/2024
02/11/2023 39 184 ( 0.01% ) 81 111 $ 31/03/2024
20/06/2023 6 916 666 ( 5.21% ) 76 083 $ 31/03/2024
29/06/2023 1 589 ( 99.94% ) 3 289 $ 31/03/2024

Posizioni attive di Marc Lustig

SocietàPosizioneInizio
IM CANNABIS CORP. Chairman 11/10/2019
PHARMACIELO LTD. Chief Executive Officer 11/07/2023
CRESCO LABS INC. Director/Board Member 29/06/2020
AEQUUS PHARMACEUTICALS INC. Director/Board Member 15/02/2021
BRIACELL THERAPEUTICS CORP. Director/Board Member 31/08/2021
TRICHOME FINANCIAL CORP. Director/Board Member 01/10/2019
Director/Board Member -
Director/Board Member -
Director/Board Member -
Tutte le posizioni attive di Marc Lustig

Precedenti posizioni note di Marc Lustig

SocietàPosizioneFine
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Marc Lustig

Formazione di Marc Lustig

McGill University Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Marc Lustig

Relazioni

100 +

Relazioni di 1° grado

25

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa8
MERCK & CO., INC.

Health Technology

IM CANNABIS CORP.

Health Technology

AEQUUS PHARMACEUTICALS INC.

Health Technology

RF CAPITAL GROUP INC.

Finance

PLANET 13 HOLDINGS INC.

Process Industries

CRESCO LABS INC.

Process Industries

PHARMACIELO LTD.

Process Industries

BRIACELL THERAPEUTICS CORP.

Health Technology

Aziende private16

Finance

Finance

Process Industries

Finance

Finance

Finance

Process Industries

Process Industries

Health Technology

Finance

Retail Trade

Finance

Cedars Cancer Foundation

Finance

Finance

Wellfield Technologies, Inc.

Vedi le connessioni aziendali